AdipoRon, adiponectin receptor agonist, improves vascular function in the mesenteric arteries of type 2 diabetic mice
Open accessAbstract
BACKGROUND: An orally active synthetic adiponectin receptor agonist, AdipoRon has been suggested to ameliorate insulin resistance, and glucose tolerance. However, the chronic effect of AdipoRon in the vascular dysfunction in type 2 diabetes has not been studied yet. Thus, in this study, we examined whether AdipoRon improves vascular function in type 2 diabetes. METHODS: Type 2 diabetic (db-/db-) mice were treated with AdipoRon (10 mg/kg/everyday, by oral gavage) for 2 weeks. Body weight and blood glucose levels were recorded every other day during the experimental period. Diameter of mesenteric arteries was measured. And western blot analysis was performed with mesenteric arteries. RESULTS: Pressure-induced myogenic response was significantly increased while endothelium-dependent relaxation was reduced in the mesenteric arteries of db-/db- mice. Treatment of AdipoRon normalized potentiated myogenic response, whereas endothelium-dependent relaxation was not affected by treatment of AdipoRon. The expression levels of AdiR1, AdiR2, APPL1, and APPL 2 were increased in the mesenteric arteries of db-/db- mice and treatment of AdipoRon did not affect them. Interestingly, AdipoRon treatment increased the phospho-AMPK and decreased MYPT1 phosphorylation in db-/db- mice while there was no change in the level of eNOS phosphorylation. CONCLUSION: The treatment of AdipoRon improves vascular function in the mesenteric arteries of db-/db- mice through endothelium-independent mechanism. We suggest that MLCP activation through reduced phosphorylation of MYPT1 might be the dominant mechanism in the AdipoRon-induced vascular effect.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
AdipoRon, an orally active synthetic adiponectin receptor agonist, improved vascular function in mesenteric arteries independently of endothelium mechanism in mice.
“Recently, an orally active synthetic adiponectin receptor agonist, AdipoRon, was developed and studied in an experimental animal study (mice) showing improvement in vascular function in the mesenteric arteries independently of endothelium-mechanism [47].”
From Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions (2021) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Weyer, C., Funahashi, T., Tanaka, S., Hotta, K., Matsuzawa, Y., Pratley, R. E., & Tataranni, P. A. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7463 · Cited by 3,541 · see citing works
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133 · see citing works
Type 2 diabetes: principles of pathogenesis and therapy
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2005) · The Lancet · doi:10.1016/s0140-6736(05)61032-x · Cited by 2,662 · see citing works
The adipocyte-secreted protein Acrp30 enhances hepatic insulin action
Berg, A. H., Combs, T. P., Du, X., Brownlee, M., & Scherer, P. E. (2001) · Nature Medicine · doi:10.1038/90992 · Cited by 2,526 · see citing works
Impact of Overweight on the Risk of Developing Common Chronic Diseases During a 10-Year Period
Field, A. E., Coakley, E. H., Must, A., Spadano, J. L., Laird, N., Dietz, W. H., Rimm, E., & Colditz, G. A. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.13.1581 · Cited by 1,694 · see citing works
Maeda, N., Takahashi, M., Funahashi, T., Kihara, S., Nishizawa, H., Kishida, K., Nagaretani, H., Matsuda, M., Komuro, R., Ouchi, N., et al. (2001) · Diabetes · doi:10.2337/diabetes.50.9.2094 · Cited by 1,659 · see citing works
On the local reactions of the arterial wall to changes of internal pressure
Bayliss, W. M. (1902) · The Journal of Physiology · doi:10.1113/jphysiol.1902.sp000911 · Cited by 1,526 · see citing works
Adiponectin: More Than Just Another Fat Cell Hormone?
Chandran, M., Phillips, S. A., Ciaraldi, T. P., & Henry, R. R. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2442 · Cited by 1,007 · see citing works
A small-molecule AdipoR agonist for type 2 diabetes and short life in obesity
Okada-Iwabu, M., Yamauchi, T., Iwabu, M., Honma, T., Hamagami, K.-I., Matsuda, K., Yamaguchi, M., Tanabe, H., Kimura-Someya, T., Shirouzu, M., et al. (2013) · Nature · doi:10.1038/nature12656 · Cited by 757 · see citing works
Adiponectin regulation and function
Fang, H., & Judd, R. L. (2018) · Comprehensive physiology · doi:10.1002/cphy.c170046 · Cited by 631 · see citing works
Adiponectin receptors: A review of their structure, function and how they work
Yamauchi, T., Iwabu, M., Okada‐Iwabu, M., & Kadowaki, T. (2013) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2013.09.003 · Cited by 355 · see citing works
Kim, Y., Lim, J. H., Kim, M. Y., Kim, E. N., Yoon, H. E., Shin, S. J., Choi, B. S., Kim, Y.-S., Chang, Y. S., & Park, C. W. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017060627 · Cited by 229 · see citing works
Kitazawa, T., Eto, M., Woodsome, T. P., et al. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2002.029306 · Cited by 228 · see citing works
Adiponectin directly improves endothelial dysfunction in obese rats through the AMPK–eNOS Pathway
Deng, G., Long, Y., Yu, Y.-R., & Li, M.-R. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.205 · Cited by 165 · see citing works
Yin-Yang Regulation of Adiponectin Signaling by APPL Isoforms in Muscle Cells
Wang, C., Xin, X., Xiang, R., Ramos, F. J., Liu, M., Lee, H. J., Chen, H., Mao, X., Kikani, C. K., Liu, F., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.010355 · Cited by 147 · see citing works
Choi, S. R., Lim, J. H., Kim, M. Y., Kim, E. N., Kim, Y., Choi, B. S., Kim, Y.-S., Kim, H. W., Lim, K., Kim, M.-J., et al. (2018) · Metabolism · doi:10.1016/j.metabol.2018.02.004 · Cited by 147 · see citing works
Self-citationDebard, C., Laville, M., Berbe, V., Loizon, E., Guillet, C., Morio, B., Boirie, Y., & Vidal, H. (2004) · Diabetologia · doi:10.1007/s00125-004-1394-7 · Cited by 145 · see citing works
Lagaud, G., Masih‐Khan, E., Kai, S., van Breemen, C., & Dubé, G. P. (2001) · Journal of Vascular Research · doi:10.1159/000051094 · Cited by 99 · see citing works
Ronning After the Adiponectin Receptors
Holland, W. L., & Scherer, P. E. (2013) · Science · doi:10.1126/science.1249077 · Cited by 79 · see citing works
Rho-kinase-mediated regulation of receptor-agonist-stimulated smooth muscle contraction
Tsai, M.-H., & Jiang, M. J. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0133-y · Cited by 73 · see citing works
APPLs: More than just adiponectin receptor binding proteins
Liu, Z., Xiao, T., Peng, X., Li, G., & Hu, F. (2017) · Cellular Signalling · doi:10.1016/j.cellsig.2017.01.018 · Cited by 58 · see citing works
Role of Endogenous ENaC and TRP Channels in the Myogenic Response of Rat Posterior Cerebral Arteries
Kim, E.-C., Choi, S. K., Lim, M., Yeon, S., & Lee, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0084194 · Cited by 51 · see citing works
Self-citationAdiponectin and its receptors: implications for obesity-associated diseases and longevity
Kadowaki, T., Yamauchi, T., Okada‐Iwabu, M., & Iwabu, M. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70120-7 · Cited by 46 · see citing works
Holmes, R. M., Yi, Z., Filippis, E. D., Berria, R., Shahani, S., Sathyanarayana, P., Sherman, V., Fujiwara, K., Meyer, C., Christ-Roberts, C. Y., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2173-x · Cited by 36 · see citing works
Expression of adiponectin and its receptors in type 1 diabetes mellitus in human and mouse retinas.
Lin, T., Qiu, Y., Liu, Y., Mohan, R. R., Li, Q., & Lei, B. (2013) · Europe PMC (PubMed Central) · Cited by 35 · see citing works
Choi, S. K., Ahn, D. S., & Lee, Y. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvp054 · Cited by 34 · see citing works
Self-citationHong, K., Lee, S., Li, R., Yang, Y., Tanner, M. A., Wu, J., & Hill, M. A. (2016) · Microcirculation · doi:10.1111/micc.12266 · Cited by 30 · see citing works
Halpern, A., & Mancini, M. C. (2005) · Treatments in Endocrinology · doi:10.2165/00024677-200504020-00001 · Cited by 24 · see citing works
Schmid, P. M., Resch, M., Schach, C., Birner, C. M., Riegger, G. A. J., Luchner, A., & Endemann, D. (2013) · Cardiovascular Diabetology · doi:10.1186/1475-2840-12-46 · Cited by 19 · see citing works
Vascular dysfunction in Type 2 diabetes: emerging targets for therapy
Park, Y., Wu, J., Zhang, H., Wang, Y., & Zhang, C. (2009) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.7.3.209 · Cited by 15 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions
de Oliveira dos Santos, A. R., de Oliveira Zanuso, B., Miola, V. F. B., Barbalho, S. M., Santos Bueno, P. C., Flato, U. A. P., Detregiachi, C. R. P., Buchaim, D. V., Buchaim, R. L., Tofano, R. J., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052639 · Cited by 189 · see citing works
- Authors
- Choi, S.-K., Kwon, Y., Byeon, S., Haam, C. E., & Lee, Y.-H.
- Affiliations
- Yonsei University (KR)
- Corresponding author
- Lee, Young-Ho
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2020-03-17
- Volume
- 15
- Issue
- 3
- Pages
- e0230227
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC7077821
- OpenAlex
- W2928833045
- Cited by
- 15
- References
- 30
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 1
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Funders
- Myoung-Sun Kim Memorial Foundation (2017)
- Topics
- Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Keywords
- AdipoRon, adiponectin receptor agonist, type 2 diabetes, vascular function, mesenteric arteries, myogenic response, endothelium-dependent relaxation, AMPK, MYPT1, endothelial nitric oxide synthase, db/db mice, insulin resistance
- MeSH terms
- Animals, Diabetes Mellitus, Experimental, Diabetes Mellitus, Type 2, Endothelium, Vascular, Insulin Resistance, Male, Mesenteric Arteries, Mice, Inbred Strains, Phosphorylation, Piperidines, Adaptor Proteins, Signal Transducing, Mice, Nitric Oxide Synthase Type III, Receptors, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
